Kritik Hastada Transfüzyon İlkeleri ve Transfüzyon Reaksiyonları
Abstract
Blood product transfusions are frequently performed during critical illnesses. Primarily; erythrocyte suspension, platelet suspension and fresh frozen plasma transfusions are performed. It should not be forgotten that these procedures, which have positive effects on the survival and healing process of patients, may also cause side effects and increase morbidity and mortality. Therefore, it is necessary to determine the indications of transfusions correctly and determine the goals according to the patient characteristics. There are many studies done in this regard. In light of these studies, several guidelines have been prepared. Through these studies and these guidelines, avoidance of unnecessary transfusions and optimum benefit in transfusions are aimed. Regarding transfusion of erythrocyte suspensions in the general population, higher target hemoglobin levels have not been shown to be superior to lower target levels. In addition, target hemoglobin levels should be individualized in septic patients and the patients with cardiovascular comorbidities. While giving platelet transfusion, the transfusion decision should be made considering the risk of spontaneous bleeding and the risk of bleeding during possible interventions. The transfusion should be avoided in cases of low bleeding risks or non-risk events. Fresh frozen plasma transfusions should be performed with correct indications and the bleeding risk should be taken into account. During and after transfusion of all blood products transfusion reactions may develop; appropriate precautions should be taken and prompt treatment should be given as needed.
Keywords
Blood Transfusion, Transfusion Reaction, Critical Illness, Erythrocyte Transfusion, Platelet Transfusion, Blood Omponent Transfusion
References
- 1. McIntyre L, Tinmouth AT, Fergusson DA. Blood component transfusion in critically ill patients. Curr Opin Crit Care 2013;19:326-333.
- 2. Kor DJ, Gajic O. Blood product transfusion in the critical care setting. Curr Opin Crit Care 2010;16:309-316.
- 3. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 2013;160:445-464.
- 4. Vincent JL, Baron JF, Reinhart K, et al. Anemia and Blood Transfusion in Critically ill Patients. JAMA 2002;288:1499-1507.
- 5. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-417.
- 6. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371:1381- 1391.
- 7. Rygard SL, Holst LB, Wetterslev J, et al. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Med 2016;42:1685-1694.
- 8. Rygard SL, Holst LB, Wetterslev J, et al. Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial. Acta Anaesthesiol Scand 2017;61:166-175.
- 9. Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016;316:2025-2035.
- 10. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227-234.